Background Many factors contribute to language development
A ntiepileptic drugs (AEDs) are the primary choice of therapy for epileptic patients at any age and gender. Treatment is sometimes prolonged and may require large doses as well as drug combinations. Therefore, the adverse effects of AEDs should be considered during treatment. One such effect is on calcium metabolism. 1, 2 Calcium plays an important role in various physiological functions in the body including the blood clotting process, sodium and potassium cell membrane potential maintainance, signal transduction between hormone receptors, neuromuscular excitability, integrity of cell membrane, enzymatic reactions, neurotransmission, and bone structure formation. Clinical symptoms of hypocalcemia range from mild to severe. In plasma with calcium concentration 50% below normal, peripheral nerve fibers become excited, spontaneously spreading impulses to the peripheral skeletal muscle and triggering tetanic muscle contractions or even seizures. Extreme hypocalcemia can cause cardiac dilatation, blood clotting disorders, and death. 3 Antiepileptic drugs have been widely reported to reduce serum calcium levels, which interferes with bone metabolism, decreasing bone density mainly through induction of the cytochrome P450 (CYP450) enzyme system in the liver. Decreased calcium levels elevate parathyroid hormone and increase bone turnover characterized by hyperphosphatemia. This mechanism mainly occurs in the group of enzyme-inducers, such as phenobarbital, phenytoin, and carbamazepine. However, recent research also showed that nonenzyme inducing AEDs, such as valproic acid, may also cause hypocalcemia through inhibitory effects of the AED metabolites on calcium ions. 1,2 These effects have been suggested to be time and dose dependent. Many studies reported that epileptic children treated with AEDs (carbamazepine or valproic acid) over a certain period of time experienced decreased total calcium levels. [4] [5] [6] Furthermore, dose reductions led to normalization of the calcium concentration. 7 The effects of AED on total serum calcium levels in epileptic children in Indonesia have not been well studied. The objective of this study was to assess for possible correlations between durations of therapy and doses of AEDs (carbamazepine or valproic acid as the most widely used AEDs in epileptic children) and total serum calcium levels.
Methods
This cross sectional study was conducted in the Neuropediatric Outpatient Department of Mohammad Hoesin Hospital, Palembang, South Sumatera, from February to April 2015. We recruited subjects by consecutive sampling. Inclusion criteria were all epileptic patients aged between 6 months to <15 years, who had undergone valproic acid or carbamazepine treatment for at least 1 month, and whose parents provided informed consent. Exclusion criteria were children with pre-existing chronic kidney disease, liver failure, malnutrition, or hypoalbuminemia, as well as those who took other AEDs, calcium or vitamin D supplementation, or steroid or diuretic therapy.
Duration of therapy was defined to be the length of AED usage on a regular basis, expressed in months. Dose of therapy was defined to be the average maintenance AED dose in the past month, expressed in mg/kg/day. Total calcium level was defined to be blood calcium level obtained through venous blood test, including calcium ions, protein-bound calcium, and organic or complex-bound calcium. Low total calcium levels (hypocalcemia) was defined as a total calcium level below the reference value, according to age. 8 We collected data on duration and dose of AEDs by history taking and retrieving data from the medical charts. Non fasting blood tests was done to measure total serum calcium level. Total calcium levels were measured by COBASS INTEGRA®.
Spearman's correlation test was used to analyze the correlation between the duration as well as the dose of valproic acid or carbamazepine and total calcium level. Significance was set at P<0.05 with 95% confidence intervals (CI).
Results
From February to April 2015, 30 epileptic children taking carbamazepine and 30 others taking valproic acid met the inclusion criteria. There were more males in the carbamazepine group and more females in the valproic acid group. The median ages in the carbamazepine and valproic acid groups were 52.5 and 57.5 months old, respectively. The median durations of therapy were 13 months in the carbamazepine group and 12 months in the valproic acid group. The median maintenance doses were 15 mg/kg/day in the carbamazepine group and 20 mg/kg/day in the valproic acid group. The mean total serum calcium levels were 9.48 mg/dL in the carbamazepine group and 9.58 mg/dL in valproic acid group. The characteristics of subjects are presented in Table 1 .
Hypocalcemia was found in 13 patients (22% of all subjects), 9 patients (30%) in the carbamazepine group and 4 patients (13%) in the valproic acid group. The distribution of subjects' total calcium levels in both groups are shown in Table 2 .
There was a statistically significant moderate correlation between the duration of carbamazepine therapy and low total serum calcium level, with a weak correlation coefficient (r=0.36; P=0.001). There was no correlation between daily carbamazepine dose with total calcium level (r=0.03; P=0.878).
For children taking valproic acid, there seems to be a weak correlation between valproic acid and total serum calcium although this was not statistically significant (r=0.35; P=0.057). No significant correlation between average daily dose of valproic acid and total serum calcium levels (r=0.11; P=0.56) was found.
Discussion
Our study demonstrated moderate correlations between total serum calcium level and carbamazepine duration of therapy. Valproic acid therapeutic duration also seemed to moderately correlate with total calcium level although this was not statistically significant. No correlations were found between daily dose of AED and total calcium level.
In the carbamazepine group, the mean total calcium level was within normal limits, and 9 subjects (30%) had total calcium levels below normal. Of the 9 subjects, the lowest calcium level was 8.1 mg/dL in 2 subjects but they had no symptoms of hypocalcemia. The best explanation of this effect was that carbamazepine activated the orphan nuclear receptor, pregnane X receptor (PXR), which shares 60% homology in their DNA-binding domains to the vitamin D receptor (VDR), and is expressed in 9 In the valproic acid group, mean calcium levels were generally within normal limits, only 4 subjects (13%) had low calcium levels according to age, and no hypocalcemia symptoms were observed in these patients either. Other reports suggested that valproic acid might cause hypocalcemia through its inhibitory effects on calcium ions by its metabolites. 1, 2, 7 Correlation analysis revealed a positive and significant correlation between duration of carbamazepine therapy and low calcium level, though the strength of correlation was weak. Median durations of therapy in carbamazepine group was found to be at 23 months. This median duration was much longer than that of a previous study (2009) that showed a significant decrease in calcium level after 60 days of therapy on a maintenance dose, and a further decrease after 90 days. 6 An Indian study conducted in 114 epileptic children treated with AEDs (carbamazepine, phenobarbital, phenytoin, valproic acid, and combinations) who initially had higher levels of calcium and vitamin D, also reported the decline of calcium and vitamin D levels after 6 months of AED therapy on maintenance doses. These contrasting results may be due to differences in methodology and/or study populations.
We found no significant correlation between carbamazepine dose and total calcium levels, in contrast to another study reporting a significant decline of vitamin D and calcium levels after 6 months carbamazepine therapy at maintenance doses. 10 Also, no significant correlation was found between duration of valproic acid therapy and total calcium level, nor between dose of valproic acid and total calcium level. In our subjects, hypocalcemia induced by AED was considered to be mild, with the largest decrease not exceeding 11% below normal calcium levels. As such, we would expect to not observe hypocalcemic symptoms. We also noted that hypocalcemia was more common in the carbamazepine group compared to the valproic acid group. Beyond the effect of elucidating the different mechanisms of hypocalcemia between drugs, this observation might provide the impetus for future research comparing AEDs' effects on calcium levels so that pediatricians can choose the appropriate AED to minimize the risk of hypocalcemia and prepare supplementation if necessary.
Some limitations of this study were that we examined total calcium levels rather than ionized calcium to represent the calcium levels because our facilities lacked the capability to examine ionized calcium levels. Another limitation is that the sample size is limited and that is why perhaps we did not pick up statistically significant correlation in the valproic acid group. Calcium ions actively play an important role in metabolism and are considered to represent 50% of total calcium. 11 The measurement of total calcium was considered sufficient to represent the state of calcium ions, especially in medical centers with limited facilities. However, the ionized calcium levels would have given better results in terms of the effects of valproic acid metabolites. Also, we did not examine the base profile levels of vitamin D and parathyroid hormone, which are known to have important roles in calcium metabolism.10 Decreased levels of calcium could possibly be due to the low levels of vitamin D or parathyroid hormone, or influenced by various factors such as sun exposure and hypoparathyroidism. Another limitation was the possibility that consumption of high calcium foods a few hours before the blood test affected total calcium levels.
In conclusion, moderate positive correlation is found between duration of carbamazepine therapy and total serum calcium. No correlation is found between daily dose of AED and total calcium level. Further study is recommended to compare AED side effects on calcium metabolism in a clinical trial.
